pubmed-article:12675197 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12675197 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:12675197 | lifeskim:mentions | umls-concept:C0007785 | lld:lifeskim |
pubmed-article:12675197 | lifeskim:mentions | umls-concept:C1423842 | lld:lifeskim |
pubmed-article:12675197 | lifeskim:mentions | umls-concept:C1327413 | lld:lifeskim |
pubmed-article:12675197 | lifeskim:mentions | umls-concept:C0851285 | lld:lifeskim |
pubmed-article:12675197 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:12675197 | pubmed:dateCreated | 2003-4-4 | lld:pubmed |
pubmed-article:12675197 | pubmed:abstractText | Chungsim-Yeunja-Tang is a prescription for the Taeumin cerebral infarction (CI) patients according to Sasang constitutional philosophy. Taeumin patients with CI were treated with CY-Tang during the acute stage. Clinical signs of CI disappeared markedly in about 2 weeks after oral administration of CY-Tang in all patients. The mean interleukin (IL)-2 plasma levels were slightly lower in the patients with CI than in the normal groups, whereas the mean TNF-alpha, IL-4, IL-6, and IgE levels were significantly higher in the patients with CI. There were no significant differences in interferon-gamma (IFN-gamma) levels between the groups. Serum IFN-gamma and IL-2 levels derived from (Th) 1 cells were significantly elevated in the patients with CI by CY-Tang administration. Significant reduced plasma levels of IL-4 and IL-6 derived from Th2 cells and IgE were observed in the patients treated with CY-Tang. Plasma levels TNF-alpha derived from Th1 significantly increased in the patients treated with CY-Tang. During the period of CY-Tang administration, there were no other adverse effects. The data indicate that CY-Tang has a good CI treatment effect, and that its action may be due to the regulation of cytokine production. | lld:pubmed |
pubmed-article:12675197 | pubmed:language | eng | lld:pubmed |
pubmed-article:12675197 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12675197 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12675197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12675197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12675197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12675197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12675197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12675197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12675197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12675197 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12675197 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12675197 | pubmed:month | Feb | lld:pubmed |
pubmed-article:12675197 | pubmed:issn | 0892-3973 | lld:pubmed |
pubmed-article:12675197 | pubmed:author | pubmed-author:KimHyung-MinH... | lld:pubmed |
pubmed-article:12675197 | pubmed:author | pubmed-author:JeongHyun-JaH... | lld:pubmed |
pubmed-article:12675197 | pubmed:author | pubmed-author:KimKyung-SukK... | lld:pubmed |
pubmed-article:12675197 | pubmed:author | pubmed-author:ChoKwang-HoKH | lld:pubmed |
pubmed-article:12675197 | pubmed:author | pubmed-author:LeeJong-DeokJ... | lld:pubmed |
pubmed-article:12675197 | pubmed:author | pubmed-author:KimKyung-YoKY | lld:pubmed |
pubmed-article:12675197 | pubmed:author | pubmed-author:SeoSun-YongSY | lld:pubmed |
pubmed-article:12675197 | pubmed:author | pubmed-author:NohHyun-SooHS | lld:pubmed |
pubmed-article:12675197 | pubmed:author | pubmed-author:ParkHye-SunHS | lld:pubmed |
pubmed-article:12675197 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12675197 | pubmed:volume | 25 | lld:pubmed |
pubmed-article:12675197 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12675197 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12675197 | pubmed:pagination | 29-39 | lld:pubmed |
pubmed-article:12675197 | pubmed:dateRevised | 2009-5-14 | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:meshHeading | pubmed-meshheading:12675197... | lld:pubmed |
pubmed-article:12675197 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12675197 | pubmed:articleTitle | Regulation of TH1/TH2 cytokine production by Chungsim-Yeunja-Tang in patients with cerebral infarction. | lld:pubmed |
pubmed-article:12675197 | pubmed:affiliation | Department of Oriental Pharmacy, College of Pharmacy, Wonkwang University, Iksan-city, Chonbuk, South Korea. | lld:pubmed |
pubmed-article:12675197 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12675197 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12675197 | lld:pubmed |